Jiabei Wang
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Hepatology 27
- Hepatocellular Carcinoma Treatment and Prognosis 24
-
- Cancer-related molecular mechanisms research 7
- Cancer, Hypoxia, and Metabolism 6
- MicroRNA in disease regulation 6
- Co-authors
- Tongsen Zheng (26 shared papers)Lianxin Liu (37 shared papers)Lianxin Liu (17 shared papers)Hongchi Jiang (19 shared papers)Yingjian Liang (17 shared papers)Shangha Pan (16 shared papers)Ruipeng Song (12 shared papers)Dalong Yin (16 shared papers)
- Journals
- Cancer Letters (6 papers)Hepatology (4 papers)Nature Communications (4 papers)Cell Death and Disease (4 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jiabei Wang
91 papers receiving 3.7k citations
Jiabei Wang's Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 883
- Hepatology 454
- Oncology 589
- Molecular Biology 892
- Biological Psychiatry 18
Countries citing papers authored by Jiabei Wang
This map shows the geographic impact of Jiabei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiabei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiabei Wang more than expected).
Fields of papers citing papers by Jiabei Wang
This network shows the impact of papers produced by Jiabei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiabei Wang. The network helps show where Jiabei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiabei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 258 | |
| 2 | 2018 | 219 | |
| 3 | 2009 | 211 | |
| 4 | 2012 | 185 | |
| 5 | 2015 | 127 | |
| 6 | 2014 | 121 | |
| 7 | 2013 | 115 | |
| 8 | 2021 | 111 | |
| 9 | 2018 | 105 | |
| 10 | Donafenib and GSK‐J4 Synergistically Induce Ferroptosis in Liver Cancer by Upregulating HMOX1 Expression Hit paper breakdown → | 2023 | 104 |
| 11 | 2013 | 99 | |
| 12 | 2022 | 97 | |
| 13 | 2013 | 92 | |
| 14 | 2019 | 80 | |
| 15 | 2014 | 76 | |
| 16 | 2021 | 75 | |
| 17 | 2010 | 74 | |
| 18 | 2016 | 73 | |
| 19 | 2013 | 66 | |
| 20 | 2015 | 65 |
About Jiabei Wang
Jiabei Wang is a scholar working on Hepatology, Cancer Research, Oncology, Cellular and Molecular Neuroscience and Molecular Biology, having authored 100 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Cancer-related Molecular Pathways (8 papers), Cancer-related molecular mechanisms research (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), MicroRNA in disease regulation (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Cancer Research (883 citations), Hepatology (454 citations), Oncology (589 citations), Molecular Biology (892 citations) and Biological Psychiatry (18 citations). Jiabei Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Tongsen Zheng, Lianxin Liu, Lianxin Liu, Hongchi Jiang, Yingjian Liang, Shangha Pan, Ruipeng Song, Dalong Yin, Xi Chen and Xianzhi Meng. Their work appears in journals such as Cancer Letters, Hepatology, Nature Communications, Cell Death and Disease and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.